knowledge -WSS

knowledge

author：entertainment 2025-10-02 19:20:04 - browse：2783

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Senators: Long

leisure time

WSS

How AI helped researchers track recovery from depression

The creative science of coining drug names

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Welsh Carson private equity firm escapes from FTC antitrust case

EpiPen alternative approval delay highlights citizen petition issue

BIO to announce reorganization, senior leaders expected to depart

hotspot

knowledge

entertainment

Peter Hotez and the public health issue of online harassment

Chemotherapy before breast cancer surgery might fuel metastasis

Cancer drug shortages should be causing more outrage

Deliver public health messages at the right time

How to save PrEP access — and even expand it

STAT Virtual Event: Putting AI to the Test

Apple is now the first public company to be valued at $3 trillion

Senators: Long

Walensky prepares to leave CDC — and Congress — behind

Chemotherapy before breast cancer surgery might fuel metastasis

hotspot

Changes to biosimilar regulatory framework must prioritize patients

Brain technologies pose threats that are all too real, experts warn

Deliver public health messages at the right time

As health system earnings go up, health insurance stocks go down

Black vets could get higher VA benefits if race not used in lung test

How AI helped researchers track recovery from depression

hotspot

knowledge

leisure time

explore